Stephen Baxter
Stock Analyst at Wells Fargo
(2.41)
# 2,506
Out of 5,132 analysts
249
Total ratings
45.62%
Success rate
-0.88%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COR Cencora | Maintains: Overweight | $405 → $429 | $360.83 | +18.89% | 6 | Feb 10, 2026 | |
| CAH Cardinal Health | Maintains: Overweight | $237 → $256 | $220.79 | +15.95% | 11 | Feb 10, 2026 | |
| MCK McKesson | Maintains: Equal-Weight | $914 → $925 | $934.75 | -1.04% | 10 | Feb 5, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $400 → $370 | $293.19 | +26.20% | 16 | Jan 30, 2026 | |
| ELV Elevance Health | Maintains: Overweight | $424 → $391 | $346.80 | +12.75% | 16 | Jan 30, 2026 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $452 → $481 | $540.29 | -10.97% | 19 | Jan 30, 2026 | |
| MDLN Medline | Initiates: Equal-Weight | $42 | $44.55 | -5.72% | 1 | Jan 12, 2026 | |
| MOH Molina Healthcare | Maintains: Overweight | $165 → $208 | $135.35 | +53.68% | 22 | Jan 7, 2026 | |
| CNC Centene | Maintains: Equal-Weight | $35 → $43 | $40.58 | +5.96% | 25 | Jan 7, 2026 | |
| PNTG The Pennant Group | Maintains: Overweight | $31 → $38 | $31.96 | +18.90% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $252 → $229 | $231.10 | -0.91% | 17 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3 → $2 | $3.42 | -41.52% | 12 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $39 → $43 | $38.86 | +10.65% | 8 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $290 | $184.10 | +57.52% | 13 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $259 → $235 | $234.81 | +0.08% | 17 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $14 → $11 | $13.42 | -18.03% | 13 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $102 | $78.48 | +29.97% | 16 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1.5 → $1 | $0.36 | +177.01% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $354 → $300 | $291.44 | +2.94% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $4.65 | +222.58% | 3 | Apr 29, 2024 |
Cencora
Feb 10, 2026
Maintains: Overweight
Price Target: $405 → $429
Current: $360.83
Upside: +18.89%
Cardinal Health
Feb 10, 2026
Maintains: Overweight
Price Target: $237 → $256
Current: $220.79
Upside: +15.95%
McKesson
Feb 5, 2026
Maintains: Equal-Weight
Price Target: $914 → $925
Current: $934.75
Upside: -1.04%
UnitedHealth Group
Jan 30, 2026
Maintains: Overweight
Price Target: $400 → $370
Current: $293.19
Upside: +26.20%
Elevance Health
Jan 30, 2026
Maintains: Overweight
Price Target: $424 → $391
Current: $346.80
Upside: +12.75%
HCA Healthcare
Jan 30, 2026
Maintains: Equal-Weight
Price Target: $452 → $481
Current: $540.29
Upside: -10.97%
Medline
Jan 12, 2026
Initiates: Equal-Weight
Price Target: $42
Current: $44.55
Upside: -5.72%
Molina Healthcare
Jan 7, 2026
Maintains: Overweight
Price Target: $165 → $208
Current: $135.35
Upside: +53.68%
Centene
Jan 7, 2026
Maintains: Equal-Weight
Price Target: $35 → $43
Current: $40.58
Upside: +5.96%
The Pennant Group
Jan 7, 2026
Maintains: Overweight
Price Target: $31 → $38
Current: $31.96
Upside: +18.90%
Jan 7, 2026
Maintains: Overweight
Price Target: $252 → $229
Current: $231.10
Upside: -0.91%
Jan 7, 2026
Maintains: Underweight
Price Target: $3 → $2
Current: $3.42
Upside: -41.52%
Jan 7, 2026
Maintains: Overweight
Price Target: $39 → $43
Current: $38.86
Upside: +10.65%
Jan 7, 2026
Downgrades: Equal-Weight
Price Target: $290
Current: $184.10
Upside: +57.52%
Jan 7, 2026
Downgrades: Equal-Weight
Price Target: $259 → $235
Current: $234.81
Upside: +0.08%
Nov 13, 2025
Maintains: Underweight
Price Target: $14 → $11
Current: $13.42
Upside: -18.03%
Nov 13, 2025
Maintains: Overweight
Price Target: $103 → $102
Current: $78.48
Upside: +29.97%
Nov 5, 2025
Maintains: Overweight
Price Target: $1.5 → $1
Current: $0.36
Upside: +177.01%
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $354 → $300
Current: $291.44
Upside: +2.94%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $4.65
Upside: +222.58%